Oncotarget: Combination of copanlisib with cetuximab improves tumor response
"These data support further investigation of PI3K inhibition in HNSCC and suggests gene expression patterns associated with PI3K signaling"
2021-02-10
(Press-News.org) Oncotarget published "Combination of copanlisib with cetuximab improves tumor response in cetuximab-resistant patient-derived xenografts of head and neck cancer" which reported that HNSCC is frequently associated with either amplification or mutational changes in the PI3K pathway, making PI3K an attractive target, particularly in cetuximab-resistant tumors.
Here, the authors explored the antitumor activity of the selective, pan-class I PI3K inhibitor copanlisib with predominant activity towards PI3Kα and δ in monotherapy and in combination with cetuximab using a mouse clinical trial set-up with 33 patient-derived xenograft models with known HPV and PI3K mutational status and available data on cetuximab sensitivity.
Combination treatment with copanlisib and cetuximab was superior to either of the monotherapies alone in the majority of the models, and the effect was particularly pronounced in cetuximab-resistant tumors.
While no correlation was observed between PI3K mutation status and response to either cetuximab or copanlisib, increased PI3K signaling activity evaluated through gene expression profiling showed a positive correlation with response to copanlisib.
Together, these data support further investigation of PI3K inhibition in HNSCC and suggests gene expression patterns associated with PI3K signaling as a potential biomarker for predicting treatment responses.
Dr. Konrad Klinghammer from The Charité - Universitätsmedizin Berlin said, "Head and neck squamous cell carcinoma (HNSCC) represents the sixth most common type of cancer with 0.65 million new cases and 0.33 million deaths annually worldwide."
Upregulated PI3K/AKT/mTOR signaling has also been shown to increase resistance to radiotherapy and cytostatic drugs, and PI3K has been defined as an alternate signaling pathway in cetuximab-resistant HNSCC.
Accordingly, based on the cancer genome atlas data, up to 56% of HNSCC display either amplification or mutational changes in the PI3K pathway, and according to the head and neck cancer tissue array data, the PI3K/AKT/mTOR pathway is upregulated in over 90% in both HPV-positive and negative HNSCCs.
Upregulated PI3K/AKT/mTOR signaling, the occurrence of mutational changes in the PI3K pathway, and emerging clinical data from trials with PI3K inhibitors make PI3K an attractive target for cancer therapy, particularly in patients with recurrent/metastatic HNSCC.
Copanlisib is a highly selective, pan-class I PI3K inhibitor with preferential activity against the p110α and p110Δ isoforms that lead to the downregulation of PI3K signaling.
To this end, a panel of altogether 33 HPV-positive or negative HNSCC PDX models were selected based on PI3KCA mutation status and cetuximab sensitivity to evaluate the efficacy of copanlisib given as monotherapy and in combination with cetuximab, and furthermore, the capacity of copanlisib to overcome resistance to cetuximab.
The Klinghammer Research Team concluded in their Oncotarget Research Paper "we demonstrated an improved tumor control by combining copanlisib with cetuximab using 33 patient-derived xenograft models and thereby establishing a preclinical rationale for the evaluation of this combination therapy in a clinical setting. A phase Ib/II study of copanlisib in combination with cetuximab in HNSCC patients harboring a PI3KCA mutation/amplification and/or a PTEN loss is currently ongoing."
INFORMATION:
Sign up for free Altmetric alerts about this article
DOI - https://doi.org/10.18632/oncotarget.27763
Full text - https://www.oncotarget.com/article/27763/text/
Correspondence to - Konrad Klinghammer - konrad.klinghammer@charite.de
Keywords - cetuximab, copanlisib, head and neck squamous cell carcinoma, HPV, patient-derived xenograft model
About Oncotarget
Oncotarget is a biweekly, peer-reviewed, open access biomedical journal covering research on all aspects of oncology.
To learn more about Oncotarget, please visit https://www.oncotarget.com or connect with:
SoundCloud - https://soundcloud.com/oncotarget
Facebook - https://www.facebook.com/Oncotarget/
Twitter - https://twitter.com/oncotarget
LinkedIn - https://www.linkedin.com/company/oncotarget
Pinterest - https://www.pinterest.com/oncotarget/
Reddit - https://www.reddit.com/user/Oncotarget/
Oncotarget is published by Impact Journals, LLC please visit http://www.ImpactJournals.com or connect with @ImpactJrnls
Media Contact
MEDIA@IMPACTJOURNALS.COM
18009220957x105
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
2021-02-10
Scientists and public health experts have long known that certain individuals, termed "super-spreaders," can transmit COVID-19 with incredible efficiency and devastating consequences.
Now, researchers at Tulane University, Harvard University, MIT and Massachusetts General Hospital have learned that obesity, age and COVID-19 infection correlate with a propensity to breathe out more respiratory droplets -- key spreaders of SARS-CoV-2, the virus that causes COVID-19. Their findings were published in Proceedings of the National Academy of Sciences.
Using data from an observational study of 194 healthy people and an experimental study of nonhuman primates with COVID-19, researchers found that exhaled aerosol particles vary greatly ...
2021-02-10
(New York, NY) February 10, 2021 - A research team led by the Icahn School of Medicine at Mount Sinai (Icahn Mount Sinai) has built the first cellular model to depict the evolution of acute myeloid leukemia (AML), from its early to late stages. By using gene editing technologies to alter genes that make cells malignant, the team was able to identify potential therapeutic targets for early disease stages. The study was reported in the journal Cell Stem Cell in February.
The therapeutic targets could be applicable not just to AML but also to the blood cancer myelodysplastic syndrome and clonal hematopoiesis, which is often a preleukemic condition.
"We essentially built from scratch a model of leukemia that characterizes the ...
2021-02-10
Global emissions of a potent substance notorious for depleting the Earth's ozone layer - the protective barrier which absorbs the Sun's harmful UV rays - have fallen rapidly and are now back on the decline, according to new research.
Two international studies published today in Nature, show emissions of CFC-11, one of the many chlorofluorocarbon (CFC) chemicals once widely used in refrigerators and insulating foams, are back on the decline less than two years after the exposure of their shock resurgence in the wake of suspected rogue production.
Dr Luke Western, from the University of Bristol, a co-lead author of one ...
2021-02-10
When we tear a muscle " stem cells within it repair the problem. We can see this occurring not only in severe muscle wasting diseases such as muscular dystrophy and in war veterans who survive catastrophic limb injuries, but also in our day to day lives when we pull a muscle.
Also when we age and become frail we lose much of our muscle and our stem cells don't seem to be able to work as well as we age.
These muscle stem cells are invisible engines that drive the tissue's growth and repair after such injuries. But growing these cells in the lab and then using them to therapeutically replace damaged muscle has been frustratingly difficult.
Researchers at the Australian Regenerative Medicine Institute at Monash University in Melbourne, ...
2021-02-10
Researchers at the Centre for Genomic Regulation (CRG) reveal that newly formed embryos clear dying cells to maximise their chances of survival. It is the earliest display of an innate immune response found in vertebrate animals to date.
The findings, which are published today in the journal Nature, may aid future efforts to understand why some embryos fail to form in the earliest stages of development, and lead to new clinical efforts in treating infertility or early miscarriages.
An embryo is fragile in the first hours after its formation. Rapid cell division and environmental stress make them prone to cellular errors, which in turn cause the sporadic death of embryonic stem cells. This is ...
2021-02-10
For nearly a century, scientists have worked to unravel the mystery of dark matter--an elusive substance that spreads through the universe and likely makes up much of its mass, but has so far proven impossible to detect in experiments. Now, a team of researchers have used an innovative technique called "quantum squeezing" to dramatically speed up the search for one candidate for dark matter in the lab.
The findings, published today in the journal Nature, center on an incredibly lightweight and as-of-yet undiscovered particle called the axion. According to theory, axions are likely billions to trillions of times smaller than electrons and may have been created during the Big Bang in humungous numbers--enough ...
2021-02-10
What The Study Did: This observational study describes differences in the number of COVID-19 deaths by nursing home racial composition and examines the factors associated with these differences.
Authors: Rebecca J. Gorges, Ph.D., of the University of Chicago, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2020.37431)
Editor's Note: The article includes funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest ...
2021-02-10
What The Study Did: This article revisits the role of dermatologists in the early HIV/AIDS epidemic for the 40th anniversary of the epidemic.
Authors: Heather Milbar, M.D., M.P.H., of the University of Pennsylvania in Philadelphia, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamadermatol.2020.5545)
Editor's Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
INFORMATION:
Media ...
2021-02-10
What The Study Did: Researchers examined changes in how organ donation from deceased donors differed by race and ethnicity in the United States over time.
Authors: Dorry L. Segev, M.D., Ph.D., of the Johns Hopkins University School of Medicine in Baltimore, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamasurg.2020.7083)
Editor's Note: The article includes conflicts of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
INFORMATION:
Media advisory: The full study is linked to this news ...
2021-02-10
Researchers in Southampton and San Francisco have developed the first compact 3D LiDAR imaging system that can match and exceed the performance and accuracy of most advanced, mechanical systems currently used.
3D LiDAR can provide accurate imaging and mapping for many applications; it is the "eyes" for autonomous cars and is used in facial recognition software and by autonomous robots and drones. Accurate imaging is essential for machines to map and interact with the physical world but the size and costs of the technology currently needed has limited LIDAR's use in ...
LAST 30 PRESS RELEASES:
[Press-News.org] Oncotarget: Combination of copanlisib with cetuximab improves tumor response
"These data support further investigation of PI3K inhibition in HNSCC and suggests gene expression patterns associated with PI3K signaling"
